Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
F. Bodur Yildirim (Ankara, Turkey), N. Sevimli (Ankara, Turkey), M. TüRk (Kayseri, Turkey), N. YiLmaz Demirci (Ankara, Turkey), A. Yurdakul (Ankara, Turkey), C. öZtüRk (Ankara, Turkey). Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer?. 2785

Member's Comments

No comment yet.

Related content which might interest you: Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 PD-L1 is a potential negative prognostic factor for non-small cell lung cancer: A 5-year-follow-up study Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011 The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients. Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Is gender a prognostic factor in long term survival non-small cell lung cancer? Source: Eur Respir J 2002; 20: Suppl. 38, 185s Year: 2002 Apelin expression is a prognostic factor in non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 HER2/Neu overexpression as independent negative prognostic factor for non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 A meta-analysis assessing the prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer Source: Virtual Congress 2021 – Innovation in thoracic surgery Year: 2021 FDG-PET SUVmax is an independent prognostic indicator in patients with non-small cell lung cancer Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 Effects of prognostic factors on survival of the patients of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 326s Year: 2005 Time in lung cancer diagnosis and its prognostic implication Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer Source: Annual Congress 2008 - New imaging techniques in chest imaging Year: 2008 Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Prognostic value of comorbidity in operated non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006 COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005 Survival and prognostic factors of oligometastatic non-small cell lung carcinoma: A single center experience Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017 Assessing the relevance of biological prognostic indices in predicting survival in non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012 Effects of pretreatment prognostic factors and treatment on survival in advanced nonsmall cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 431s Year: 2003 Tumour metabolic-flow difference as a potential predictor of survival in non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Staging of lung cancer Year: 2010